Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors by Ashokkumar Dilly, Brendon D. Honick, Yong J. Lee, David L. Bartlett, Haroon A. Choudry

Subjects: “…MUC2; mucinous colon/appendix cancer; MEK…”
Get full text

Appendicovesical Fistula, as the First Presentation of Mucinous Adenocarcinoma of Appendix: A Case Report by Narjes Mohammadzadeh, Seyed Mohammad Mahdi Hashemi

Subjects: Get full text

Current Status of Treatment among Patients with Appendiceal Tumors—Old Challenges and New Solutions? by Katarzyna Chawrylak, Magdalena Leśniewska, Katarzyna Mielniczek, Katarzyna Sędłak, Zuzanna Pelc, Sebastian Kobiałka, Timothy M. Pawlik, Wojciech P. Polkowski, Karol Rawicz-Pruszyński

Subjects: Get full text

Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies—A Comprehensive Review by Mihai Adrian Eftimie, Gheorghe Potlog, Sorin Tiberiu Alexandrescu

Subjects: Get full text

Establishment and validation of the survival prediction risk model for appendiceal cancer by Tao Liu, Tao Liu, Junli Mi, Junli Mi, Yafeng Wang, Yafeng Wang, Wenjie Qiao, Chenxiang Wang, Chenxiang Wang, Zhijun Ma, Cheng Wang

“…ObjectiveEstablishing a risk model of the survival situation of appendix cancer for accurately identifying high-risk patients and developing individualized treatment plans.MethodsA total of 4,691 patients who were diagnosed with primary appendix cancer from 2010 to 2016 were extracted using Surveillance, Epidemiology, and End Results (SEER) * Stat software. …”
Get full text

Undisclosed Surgical Incentives Compromise Informed Consent by Randi Belisomo

“…It is important to note that in this series, the five-year overall survival rate for appendix cancer treated with HIPEC, its original intent, was greater than 66 percent. …”
Get full text

Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix by Dalia Kaakour, Garrett Ward, Maheswari Senthil, Farshid Dayyani

“…Repeat CRS and HIPEC have been shown to be feasible in selected patients with GI peritoneal carcinomatosis (PC), among which those with appendix cancer receive the greatest benefit. The peritoneal cancer index (PCI) and completeness of cytoreduction have been shown to be important predictors of outcomes. …”
Get full text

Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors by Philipp Horvath, Can Yurttas, Stefan Beckert, Alfred Königsrainer, Ingmar Königsrainer

“…Median overall survival rates for patients in group 1 and 2 for colon cancer, ovarian cancer, gastric cancer and appendix cancer were 34 and 25 months; 45 months and not reached; 30 and 16 months; 39 months and not reached, respectively. …”
Get full text

Peritoneal Carcinosis: What the Radiologist Needs to Know by Alfonso Reginelli, Giuliana Giacobbe, Maria Teresa Del Canto, Marina Alessandrella, Giovanni Balestrucci, Fabrizio Urraro, Gaetano Maria Russo, Luigi Gallo, Ginevra Danti, Barbara Frittoli, Luca Stoppino, Daria Schettini, Franco Iafrate, Salvatore Cappabianca, Andrea Laghi, Roberto Grassi, Luca Brunese, Antonio Barile, Vittorio Miele

“…It is a serious condition that can result from many different types of cancer, including ovarian, colon, stomach, pancreatic, and appendix cancer. The diagnosis and quantification of lesions in peritoneal carcinosis are critical in the management of patients with the condition, and imaging plays a central role in this process. …”
Get full text